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ABSTRACT 
Using fluorescence spectroscopy system with the fibre-optical probe, we investigated the dynamics of propagation and 
circulation in the microcirculatory system of experimental nanocapsules fluorescent-labelled (rhodamine TRITC) 
nanocapsules. The studies were carried out in clinically healthy Wistar rats. The model animals were divided into control 
group, and the group received injections of the nanocapsules. The fluorescent measurements conducted transcutaneously 
on the thigh surface. The administration of the preparation with the rhodamine concentration of 5 mg/kg of animal weight 
resulted in a twofold increase of fluorescence intensity by reference to the baseline level. As a result of the study, it was 
concluded that fluorescence spectroscopy can be used for transdermal measurements of the rhodamine-loaded capsules in 
vivo. 
Keywords: nanocomposite polymeric capsules, fluorescent labelled particles, rhodamine TRITC, drug delivery, 
fluorescence spectroscopy, blood microcirculation, optical measurements in vivo  
 
1. INTRODUCTION  
Conventional control of administrated substance distribution in animals requires specimen preparation including staining 
the tissue to determine the location and concentration of the analyte. Usually, the invasive and destruction tests cannot be 
applied to record the dynamics of the distribution processes at a certain period. At present, the methods of the in vivo 
measurements undergo rapid development. Such approaches appear promising to make possible for researchers to measure 
in a point of the research object or to do imaging of the entire body and revealing the related biological processes in the 
living animals in dynamics. In most cases, it needs minimally invasive intervention or does not need one at all.1 In this 
situation the optical diagnostics, and photonics-based techniques are of particular interest in the field of research because 
of their high sensitivity, versatility, and low cost. To obtain reliable information from an intact organism, various optical 
methods have already been developed and used for many years in the community of drug discovery to conduct studies in 
vivo.2 For example, previously optical coherence tomography (OCT) was effectively used to assess the effectiveness of 
delivery of a percutaneous vaccine.3,4 Intravital microscopy (IVM) was used for the non-invasive continuous 
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monitoring of drug movement in the body5 as well as the photoacoustic (PA) imaging has been successfully applied to 
visualize the transport and accumulation of substances in the organ or tumour tissue.6,7 The laser-induced fluorescence 
techniques also can be assigned to the group of methods. The diagnostic approach has considerable potential for drug 
discovery, not only during the development of a new drug formula but also in preclinical and clinical trials.8,9 Optical 
methods, in particular, fluorescent spectroscopy, are promising tools for diagnostics in the modern medical practice as 
well10.  
 Another vibrant area of modern study is targeted delivery of medicines, which can significantly improve the effectiveness 
of treatment of various diseases, reduce the occurrence of possible adverse side effects and disease complications. The 
creation of such controlled-release preparations in many cases is associated with the development of a microscopic 
nanoscale system, such as capsules for loading biologically active substances and delivering them directly to the target. 
Thus, encapsulation of biologically active materials for drug delivery in vivo is a complex task requiring significant 
fundamental and applied research including the development of nanocapsules for the substance transportation as well as 
the technology of in vivo control of the delivery in the body. One of the recent advancements in the field is the creation of 
porous inorganic nanoparticles that will have a high chemical and mechanical stability, being at the same time extremely 
flexible in their physical and chemical properties. As a transport container, the particles can be loaded with various 
components. Besides the labelling by a fluorescent agent makes it possible to control the delivery efficiency by optical 
method.11,12 
In this study, using a fluorescence spectroscopy the distribution the circulation of the fluorescent labelled polymer particles 
in the blood circulatory system was assessed in a rat model. The study aimed to find informative points (areas) on the rat 
skin for transcutaneous fluorescence measurements and to investigate the dynamics of the propagation of the fluorescent-
labelled (Rhodamine TRITC) nanocapsules injected in the circulatory system. 
2. THE METHOD OF RESEARCH  
The fluorescence spectroscopy system with fibre-optical probe “LAKK-M” (SPE “LAZMA” Ltd, Russia) was used for 
the in vivo measurements13,14. The system provides multiwavelength excitation, detects emission, and processes the 
fluorescence signal. Its light sources include fluorescence excitation in UV (wavelength = 365 nm, power = 1.5 mW),  blue 
(wavelength = 450 nm, power = 3.5 mW) and green light (wavelength = 532 nm, power = 4.5 mW). The abovementioned 
fluorescence excitation powers are provided at the tip of fibre probe, which induces an excitation light flux in the tissue of 
no more than 0.16 W m−2 for 365 nm, 0.37 W m−2 for 450 nm and 0.47 W m−2 for 532 nm. The spectrometer was a 
polychromator with a diffraction grating, and a CCD line (TCD1304AP, Toshiba, Tokyo, Japan) was used as the detector. 
 
 
 a) RAT b) 
Figure 1. Exterior view of the experimental setup (a) and the fibre diagnostic probe (b) used in the study 
 
The microcapsules were prepared by using calcium carbonate (CaCO3) particles as a sacrificial template. CaCO3 particles 
were prepared according to the standard method described by Parakhonskiy et. al.12 The CaCl2 (0.33 M) and Na2CO3 (0.33 
M) aqueous solutions, which was dissolved 20ml ethylene glycol, mixed under vigorous stirring for 3h, leading to the 
precipitation of CaCO3 particles. When the process was finished, a CaCO3 washed with pure water to remove the unreacted 
species. The spherical CaCO3 particles with an average diameter of 500±100 nm were prepared. The structure of polymeric 
capsule shells included biodegradable polyelectrolytes dextran sulfate (DsS, MW > 70 000), poly-L-arginine hydrochloride 
(PARG, MW > 70 000). The combination of PARG and DS is mostly used for preparation bio-capsules via layer-by-layer 
method15. The process of layer-by-layer polymer film assembly is based on the interaction and self-organization of 
complementary macromolecule pairs with the formation of a water-insoluble complex on the template surface. The process 
begins with the adsorption of the polycation (pArg) from the aqueous solution onto the negatively charged surface of the 
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template. At the next step, the polyanion (DS) is adsorbed onto the positively charged surface of the template and again 
the sign of the surface charge of the template changes to negative. A step-by-step repetition of the described procedure 
leads to the formation of the template surface of a water-insoluble polyanion/polycation complex (Fig. 2a). After CaCO3 
core was removed by ethylenediaminetetraacetic acid disodium salt (EDTA). The capsules were labelled with a fluorescent 
dye rhodamine TRITC (Fig. 2b). Tetramethylrhodamine (TRITC) is a bright red-fluorescent dye with excitation ideally 
suited to the 557 nm laser line. Using this wavelength, we can observe all epidermis as well as a papillary layer of the 
dermis, so it allows validating the presence of the nanocapsules deep in microcirculatory vessels of the skin. The 
characterization of obtained microcapsules was carried out using confocal laser scanning microscopy (CLSM), scanning 
electron microscopy (SEM). 
  
Figure 2. Capsules morphology analysis. Scanning electron microscopy (SEM) (a) and confocal laser scanning microscopy  
(CLSM) (b) of polyelectrolyte nanocomposite capsules. The SEM measurements (a) demonstrated the integrity of the 
nanofunctionalized shells and hollow inner cavity. The scan from CLSM analysis (b) was obtained using the spectrum 
excitation and emission for rhodamine TRITC dye. The CLSM data indicated low microcapsule aggregation and their 
spherical shapes and confirmation of high fluorescent signal 
Experimental studies were carried out on groups of clinically healthy Wistar rats, formed by the analogue method. The 
animals were held in quarantine for two weeks in the vivarium of the Centre of Preclinical Research, CJCR “Retinoids”, 
with temperature, humidity, bacterial contamination and day-night cycle control conditions under the ethical committee 
control concerning the Good Laboratory Practice Principles (GLP). Each day during the quarantine the animals were 
observed and supervised by the veterinary doctor, after that, they were randomised into two groups in according with their 
weight medians. During the experiment, the rats were anaesthetised with Zoletil 100 (Virbac, France) in standard doses. 
The model animals were divided into two groups, which outside analysis received the same food. In the study twelve 100-
120 g, Wistar rats were divided into two groups: treated with rhodamine-loaded capsules, injected directly into the 
bloodstream (n = 6), and the control one (n = 6). Before the administration of the drug, a background fluorescence 
measurement procedure was performed at one excitation wavelength of 532 nm (Fig. 1b), and due to the better 
repeatability, the points of measurements on rats’ thigh were selected. Treated group of rats received injections of 
rhodamine particles into the tail vein. The concentration of the resulting rhodamine in the group was 5 mg/kg of animal 
weight. Fluorescence spectra were recorded from thighs of anaesthetised rats during 90 min with 10 min intervals. 
Preliminary series of the measurements of the repeatability of the skin fluorescence intensity was conducted in control 
group. Before each measurement, the skin was previously depilated and cleaned with 96% ethanol solution. After an 
experiment, the animals were euthanised in the CO2 cage. 
The experimental studies complied with EU Directive 2010/63/EU, which defines a human attitude towards animals and 
refers to the Three Rs principles (replacement, reduction, and refinement). All studies were approved by the Ethical 
Committee of Orel State University. 
3. RESULTS AND DISCUSSION 
The obtained fluorescence spectra show a statistically significant increase in the fluorescence intensity in a group of rats 
received nanocapsules with rhodamine. In this group, a significant increase (from 42±5 to 100±7 a.u., twofold to the 
baseline level) at the wavelength of the peak of the rhodamine TRITC fluorescence intensity (about 590 nm) was registered 
(Fig. 3). 
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Figure 3. Fluorescence spectra in the control group (a) and in the group received fluorescent-labelled (rhodamine TRITC) 
nanocapsules (b) 
The fluorescence intensity maximum were normalised by the: 
  max
max
f
bs
I
k
I I


 , (1) 
Where 
fk  – normalised fluorescence intensity; maxI  – represents registered fluorescence intensity at 590 nm; bsI  – 
represents the maximum intensity of the backscattered laser radiation (532 nm). 
The normalised procedure is necessary to compensate variable absorption in the skin and to get more reliable 
measurement results (Fig. 4). 
  
 
Figure 4. Dynamics of the intensity of normalized fluorescence in the control group (a) and in the group received 
fluorescent-labelled (rhodamine TRITC) nanocapsules (b) 
Conducted processing of the registered experimental spectra has shown that the immediate transient process after particles 
administration is feebly marked. It can be explained by the relatively small impact of the direct dye fluorescence from the 
blood in the overall registered signal. The similar result by the same probe was obtained by the authors for liposomal 
particles in previous studies.8,9 The diagnostic volume and depth for the fluorescence measurements for the different 
excitation wavelengths for the fiber optical probe were also assessed by the Monte Carlo modelling previously.16  
  Based on the results of the study, it was found that the nanocapsules contribute to the distribution and accumulation of 
the dye in tissue. Over time, the fluorescence of the tissue increases significantly in the group where the rats received 
A B 
A B 
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particles. Previously it was shown, that the size of the particles plays a crucial role in the ability to leave the blood stream.17 
The particles of the size below than 500 um can penetrate through the vessel wall (especially through the capillary wells).18 
Thus, the observed rising trend of the normalised fluorescence in the group received the particles can be explained by the 
accumulation of the dye in the skin layers. In case of the application of patch-based microneedles with rhodamine loaded 
biodegradable polymer particles in the rat model the 50% increase of the amount of permeated dye in the skin can be 
achieved after a lapse of 5 hours.19 In the study, the 50% increase of the skin normalised fluorescence was achieved after 
1.5 hours. In case of the liposomal fluorescein loaded particles, the same level of increase was observed by authors after 
0.5 hours.8  
4. CONCLUSION 
 
In this study, we used the fluorescence spectroscopy to evaluate the penetration efficiency of nanocapsules from 
the circulatory system into adjacent tissues. Since porous containers have the potential to capture a significant amount of 
a fluorescent dye, one of methods for evaluating the effectiveness of transport can be measurements of the fluorescence 
intensity in the place of the body. The obtained fluorescence spectra show a statistically significant increase in fluorescence 
intensity in a group of rats that received nanocapsules with rhodamine. In this group, a significant increase (twofold of the 
baseline level) in the peak fluorescence intensity of used dye from 42±5 to 100±7 a.u. was registered.  
The results show that the fluorescence spectroscopy can be used to transcutaneously measure the concentration dynamics 
of labelled particles in vivo. The approach can increase the statistical significance and reliability of preclinical trials and 
reduce the required number of animals providing valuable information about pharmacodynamics and the optimal dosage 
of the drug. The results can be used in the field of preclinical drug research to control and ensure the possible drug-in-
place delivery as well as in the process of high-throughput screening during their trials. Future studies will be focused on 
the implementation of targeted delivery - the creation of directional transport systems for medicines delivered to the 
particular type of tissue. 
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